We report a case of a slowly progressive unilateral visual field defect associated with an atypical retrobulbar optic nerve sheath lesion in the context of concurrent breast cancer, which was ...
A comprehensive new review led by Mayo Clinic is helping shape how clinicians diagnose and treat meningioma, the most common primary brain tumor, with a focus on personalized, patient-centered care ...
Andrew G. Lee, MD, and Drew Carey, MD, review how clinical and imaging findings relate to vision recovery after radiotherapy for optic nerve sheath meningioma. Lee is the chair of the Blanton Eye ...
Some animals, including yaks and Tibetan antelopes, thrive at high elevations where oxygen levels are low. In humans, however, insufficient oxygen during development can lead to problems such as ...
The vagus nerve has quietly shaped how our bodies function for thousands of years. Recently, it has moved into the spotlight, especially in wellness culture, where manipulating it is often described ...
The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...
People hospitalized for a debilitating migraine should receive targeted nerve blocks rather than IV opioids to quell their pain, a major update of treatment guidelines suggests. Doctors should use a ...
Parasagittal meningiomas are tumors located in the middle space of the brain, between the two hemispheres. They can also grow into a nearby vein called the superior sagittal sinus. Most parasagittal ...
The FDA is giving a thumbs-down to this celeb-loved glow-up procedure. While it’s meant to help combat everything from wrinkles and hyperpigmentation to acne scars and stretch marks, there are now ...
Please provide your email address to receive an email when new articles are posted on . Idebenone has a Prescription Drug User Fee Act date of Feb. 28, 2026. Positive results in the phase 3 RHODOS and ...
New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...
A retrospective cohort study suggested that users of GLP-1 receptor agonists had a 7% higher incidence of new-onset diabetic retinopathy. In patients with existing diabetic retinopathy, use of GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results